Share a link:
https://casecent.re/p/21252
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
Production of human and veterinary therapeutic goods from transgenic plants is likely to be one of the most significant areas of application of biotechnology in the 21st century. It has the potential to grow into a major user of plants alongside traditional agriculture growing plants for food. The plants can be harvested and processed, and the desired product extracted and purified without any of the problems that arise in chemical synthesis or in production of therapeutic goods by domestic animals such as cows or pigs. A Danish biotech entrepreneur, Dr Lars Berglund, is excited by these developments, and has identified a novel area for application of this new technology: the expression of human intrinsic factor by transgenic plants. Vitamin B12 is the most complex of the vitamins identified so far, being built as a complex molecule around a central cobalt.
About
Abstract
Production of human and veterinary therapeutic goods from transgenic plants is likely to be one of the most significant areas of application of biotechnology in the 21st century. It has the potential to grow into a major user of plants alongside traditional agriculture growing plants for food. The plants can be harvested and processed, and the desired product extracted and purified without any of the problems that arise in chemical synthesis or in production of therapeutic goods by domestic animals such as cows or pigs. A Danish biotech entrepreneur, Dr Lars Berglund, is excited by these developments, and has identified a novel area for application of this new technology: the expression of human intrinsic factor by transgenic plants. Vitamin B12 is the most complex of the vitamins identified so far, being built as a complex molecule around a central cobalt.